Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Neith Corporation (6236:TWSE), powered by AI.
Neith Corporation is currently trading at $19.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Neith Corporation on Alpha Lenz.
View Neith Corporation's valuation metrics on Alpha Lenz.
“Neith Corporation's ROE is 2.0%. Explore profitability and growth together.”
Ask for details →Neith Corporation is a diversified healthcare and technology company based in Taichung, Taiwan, primarily operating in the biotechnology, medical cosmetics, and preventive medicine sectors. Founded in 1997, Neith Corporation develops and markets a wide array of products, such as nutritional supplements like L-One for eye health and EPlus enzyme blends, energy-focused mattresses and wearable devices, advanced water purifiers, and a comprehensive line of beauty and skincare items that support cell regeneration and rejuvenation. The company also offers genetic testing services and is active in the distribution of preventive health solutions. Notably, in some contexts, Neith Corporation is additionally classified under the semiconductor industry due to its inclusion of microcontrollers and peripherals in its portfolio, reflecting the firm’s engagement at the intersection of healthcare products and technology innovation. With a distinct emphasis on holistic well-being and technological enhancement, Neith Corporation plays a multifaceted role in Taiwan’s healthcare and consumer wellness market, catering to individuals seeking both advanced medical care solutions and lifestyle-enhancing energy products.
“Neith Corporation's ROE is 2.0%. Explore profitability and growth together.”
Ask for details →Neith Corporation (ticker: 6236) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 19 with a P/E ratio of -x and P/B of -x.
ROE is 2.04% and operating margin is -2.55%. Annual revenue is $36M.